...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: A taxable versus a non taxable sale

DM discusses this on his webcast...I want to know “how does he avoid a taxable sale when we all have a zero basis in the stock...and this company should sell in excess of $10 per share at the appropriate time....maybe in 2019?

Share
New Message
Please login to post a reply